Successful treatment of congenital myasthenic syndrome caused by a novel compound heterozygous variant in RAPSN.
Saito M, Ogasawara M, Inaba Y, Osawa Y, Nishioka M, Yamauchi S, Atsumi K, Takeuchi S, Imai K, Motobayashi M, Misawa Y, Iida A, Nishino I.
Saito M, et al. Among authors: yamauchi s.
Brain Dev. 2022 Jan;44(1):50-55. doi: 10.1016/j.braindev.2021.09.001. Epub 2021 Sep 23.
Brain Dev. 2022.
PMID: 34565654